News Releases

August 30, 2022

Seer to Participate in the Morgan Stanley Global Healthcare Conference

August 23, 2022

Seer Announces Publication of Seminal Study Demonstrating the Power of Engineered Nano-Bio Interactions to Enable Deep Access to the Proteome

August 9, 2022

Seer Reports Second Quarter 2022 Financial Results

August 3, 2022

Seer Launches First-of-its-kind Proteogenomics Workflow to Link Genetic Changes with Protein Variants with Proteograph™ Analysis Suite 2.0

July 14, 2022

Seer to Report Second Quarter 2022 Financial Results on August 9, 2022

May 4, 2022

Seer Reports First Quarter 2022 Financial Results

April 28, 2022

Seer to Present at the BofA Securities 2022 Healthcare Conference

April 7, 2022

Seer to Report First Quarter Financial Results on May 4, 2022

March 16, 2022

Seer Announces Appointment of Scott D. Thomas as Chief Commercial Officer

March 14, 2022

Seer Announces Publication of Seminal Study Demonstrating Superior Performance of Technology Platform for Deep, Unbiased, Precise, Scalable Proteomics in the Proceedings of the National Academy of Sciences